Giulia Ramacciotti
Overview
Explore the profile of Giulia Ramacciotti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Montalto N, Battocchio S, Contro G, Gaudioso P, Mularoni F, Ruaro A, et al.
Head Neck
. 2024 Dec;
47(4):1223-1238.
PMID: 39688006
Introduction: The anatomy of the tongue is three-dimensionally complex and is thought to play a central role in the local growth of oral tongue squamous cell carcinoma (OTSCC). Understanding patterns...
2.
Contro G, Sordi A, Taboni S, Citterio M, Ruaro A, de Lucia G, et al.
JAMA Otolaryngol Head Neck Surg
. 2023 Dec;
150(2):142-150.
PMID: 38153706
Importance: The tongue and oral floor represent the most involved subsite by oral cancer, and there are no reported systems to classify anteroposterior tumor extension with prognostic effect. In other...
3.
Nordio S, Maistrello L, DImperio D, Favaretto N, Dellai A, Montino S, et al.
Acta Otorhinolaryngol Ital
. 2023 Mar;
43(1):12-19.
PMID: 36860145
Objective: In the dysphagic patient, pharyngeal residues (PR) are associated with aspiration and poor quality of life. The assessment of PR using validated scales during flexible endoscopic evaluation of swallowing...
4.
Franz L, Alessandrini L, Ottaviano G, DI Carlo R, Fasanaro E, Ramacciotti G, et al.
Pathol Res Pract
. 2020 Aug;
216(9):153120.
PMID: 32825972
Background: The prognostic role of programmed death-ligand 1 (PD-L1) expression and the tumor's immune microenvironment has yet to be investigated in the specific setting of adjuvant postoperative radiotherapy (PORT) for...
5.
Munari S, Colangeli R, Ramacciotti G, Zanoletti E
J Int Adv Otol
. 2020 Aug;
16(2):286-290.
PMID: 32784169
Chordomas are the rare malignant bone lesions derived from the embryonic notochord. They are slow-growing tumors with a locally aggressive behavior. The clival chordomas are extradural, exophytic, and lytic lesions...
6.
Marioni G, Lionello M, Marchese-Ragona R, Fasanaro E, Valentini E, Zanoletti E, et al.
Int J Biol Markers
. 2017 Sep;
33(1):79-86.
PMID: 28885660
Background: The most important adverse prognostic factor for laryngeal squamous cell carcinoma (LSCC) is the presence of cervical lymph node metastases. The supraglottic area of the larynx is richly supplied...
7.
Aimoni C, Ciorba A, Hatzopoulos S, Ramacciotti G, Mazzoli M, Bianchini C, et al.
Med Sci Monit
. 2016 Aug;
22:3035-42.
PMID: 27567995
BACKGROUND Cochlear implants (CIs) have been recognized as a safe and effective means for profound hearing loss rehabilitation in children and adults and recently their use has been extended to...
8.
Brescia G, Marioni G, Franchella S, Ramacciotti G, Pendolino A, Callegaro F, et al.
Acta Otolaryngol
. 2015 Jul;
135(11):1200-4.
PMID: 26149297
Conclusions: The preliminary finding of significantly lower eosinophilic-type CRSwNP recurrence rates in patients with associated asthma or ASA intolerance treated post-operatively with local nasal and oral steroids warrants further investigation...
9.
Brescia G, Marioni G, Franchella S, Ramacciotti G, Giacomelli L, Marino F, et al.
Eur Arch Otorhinolaryngol
. 2015 Mar;
273(3):655-60.
PMID: 25763571
Even after appropriate surgical therapy, a significant number of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) experience recurrences. The end-point of this prospective study was to apply univariate and...
10.
Brescia G, Marioni G, Franchella S, Ramacciotti G, Velardita C, Giacomelli L, et al.
Am J Otolaryngol
. 2015 Feb;
36(4):554-8.
PMID: 25702570
Purpose: Despite improved surgical and medical therapies, recurrence remains a significant problem in chronic rhinosinusitis with nasal polyps (CRSwNP), given a recently-reported long-term revision rate of 15%-20%. In this prospective...